A Systematic Review of Aripiprazole-Dose, Plasma Concentration, Receptor Occupancy, and Response: Implications for Therapeutic Drug Monitoring
Anna Sparshatt, David Taylor, Maxine X Patel, Shitij Kapur
The Journal of Clinical Psychiatry | PHYSICIANS POSTGRADUATE PRESS | Published : 2010
Awarded by National Institute for Health Research
Dr Taylor has received consultancies fees, lecturing honoraria, and/or research funding from AstraZeneca, Janssen-Cilag, Servier, sanofi-aventis, Lundbeck, Bristol-Myers Squibb, Novartis, Eli Lilly, and Wyeth. Dr Patel has received consultancies fees, lecturing honoraria, and/or research funding from Janssen-Cilag, Eli Lilly, and Wyeth. Dr Kapur has received grant support or has been a consultant/scientific advisor or on speaking engagements for AstraZeneca, Bristol Meyers Squibb, Eli Lilly, EMD Darmstadt, GlaxoSmithKline, Janssen (Johnson and Johnson), Neuromolecular Inc, Otsuka, Organon, Pfizer, Sanofi-Synthelabo, Servier, Solvay, and Wyeth. Ms Sparshatt has no personal affiliations or financial relationships with any commercial interest to disclose relative to the article.